Literature DB >> 19124069

Genotoxicity of plumbagin and its effects on catechol and NQNO-induced DNA damage in mouse lymphoma cells.

Jemal Demma1, Karl Hallberg, Björn Hellman.   

Abstract

Plumbagin, a naphtoquinone present in the roots of Plumbago zeylanica, has been reported to have many beneficial effects such as antibacterial, antifungal, anticancer, antimutagenic and antioxidant effects, but this compound has also been reported to have many side effects. Given the wide use of P. zeylanica in traditional medicine and the various potential therapeutic uses of plumbagin, the present study was carried out to further elucidate the potential genotoxicity and antigenotoxicity of plumbagin in mouse lymphoma L5178Y cells, using the comet assay. Without affecting the cell viability, plumbagin itself was found to induce significant DNA damage at concentrations as low as 0.25 ng/ml. When the cells were exposed to non-DNA damaging concentrations of plumbagin, together with NQNO (known to interact with DNA in many different ways) or catechol (known to induce oxidative DNA damage), plumbagin was found to significantly reduce the catechol-induced DNA damage, but to be without protective effect against the NQNO-induced damage. The fact that non-DNA damaging concentrations of plumbagin diminished the DNA damage induced by catechol, provides further support for the idea that plumbagin may act as an antioxidative agent at low concentrations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19124069     DOI: 10.1016/j.tiv.2008.12.007

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  6 in total

1.  Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles.

Authors:  Priya Srinivas; Chitta Ranjan Patra; Santanu Bhattacharya; Debabrata Mukhopadhyay
Journal:  Int J Nanomedicine       Date:  2011-09-23

2.  The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation.

Authors:  Ju-Hee Lee; Ji-Hyun Yeon; Hanna Kim; Whijae Roh; Jeiwook Chae; Han-Oh Park; Dong-Myung Kim
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

3.  Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathways.

Authors:  Yan Jia; Ji Jing; Yang Bai; Zhen Li; Lande Liu; Jian Luo; Mingyao Liu; Huaqing Chen
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

4.  Plumbagin triggers redox-mediated autophagy through the LC3B protein in human papillomavirus-positive cervical cancer cells.

Authors:  Vaiyapuri Subbarayan Periasamy; Jegan Athinarayanan; Girija Ramankutty; Mohammad A Akbarsha; Ali A Alshatwi
Journal:  Arch Med Sci       Date:  2020-11-20       Impact factor: 3.318

5.  Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approaches.

Authors:  Mohammad S Jamal; Shadma Parveen; Mohd A Beg; Mohd Suhail; Adeel G A Chaudhary; Ghazi A Damanhouri; Adel M Abuzenadah; Mohd Rehan
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

Review 6.  Quinonoids: Therapeutic Potential for Lung Cancer Treatment.

Authors:  Hua-Zhong Ying; Chen-Huan Yu; Hao-Kun Chen; Huan-Huan Zhang; Jie Fang; Fang Wu; Wen-Ying Yu
Journal:  Biomed Res Int       Date:  2020-04-06       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.